-
Stocks move lower despite oil prices dropping
-
Brazil's patron saint pulled into latest election scrap
-
AI driving up innovation investment: UN
-
Football overload leaves players near 'breaking point', warns Tebas
-
UN Security Council extends Haiti mission by 6 months
-
Paris Eiffel Tower says chief to step down after uproar over removing women staff
-
Man Utd do not deserve medals if Man City stripped of titles: Rooney
-
Amaze Holdings (NYSE: AMZE) Executes Binding LOI to Acquire BullionFX | Alchemy, a Decentralized Gold-Backed Financial Ecosystem for Valued at US$155 Million
-
Vana Completes Expanded Staking as Part of the Vega Upgrade, Publishes Expanded VANA Token Economics
-
Clashes between French teens, police as school blockades intensify
-
Spain to cap gas price hikes, extend fuel discounts
-
Stocks move sideways despite oil moving lower
-
'We just need rain': Germany's Rhine river hits new low
-
African leaders to gather in Egypt for business summit
-
Yemen health system at 'breaking point': WHO
-
UK decides against charging foreign visitors for museums
-
Ireland undecided on second Israel match: coach
-
Dallaglio to sell England World Cup winners' medal
-
France's Le Pen defiant after top ally hit by antisemitism claims
-
Brazil come from behind to beat Australia 4-2 in friendly
-
Tom Cruise trades stunts for satire as toxic tycoon 'Digger'
-
Ruthless An retains Asian Games badminton crown as Kunlavut triumphs
-
MEXC Unveils "WE SEE YOU" Brand Visual Refresh, Putting People Behind Every Trade in Focus
-
Alonso to stay with F1 team Aston Martin in 2027
-
Thai capital cleans up after deadly floods
-
China badminton 'still strong' despite Asian Games slump
-
NATO, EU allies rally to Estonia after 'sabotage' blamed on Russia
-
'Exceptional' Turner painting shown in Rome before sale
-
Families demand justice for Cameroon's 'nightmare' wave of murdered women
-
European stocks climb as oil dips
-
Tebas says Man City should face 'most severe' sanctions if guilty of rule breaches
-
Spain aims to ban evictions until 2030 amid housing protests
-
Pochettino calls Man City success 'a period of deception'
-
Kunlavut first Thai man to win Asian Games badminton singles gold
-
Settler attack on West Bank village injures Israeli forces, drawing rare rebuke
-
French far right says antisemitism claims part of 'total war' to derail presidency bid
-
Mystery over UK airbase scare after reports no explosives found
-
'Gift from God': Rain brings relief from Indonesia toxic haze
-
Spanish govt races to adopt housing law under protest pressure
-
Ex-world snooker champion jailed for 7 years for child sex crimes
-
Estonia slams Russian 'sabotage' after arson attack on defence company
-
French teens clash with police as school blockades intensify
-
Slovenia sees surge in '.si' sites after Trump hypes 'super intelligence'
-
FIFA accuses UEFA of 'misinformation campaign' in bid for World Cup papers
-
'Like a dream' for An as Games organisers 'sorry' for latest mix-up
-
Myanmar airstrike toll hits 50 as families gather dead
-
Tokyo suffers longest streak of rainy days on record
-
STARTRADER Raises Lloyd's of London Client Fund Insurance to USD 30 Million in Aggregate
-
Indonesia charges train driver over crash that killed 16 women
-
North Korean DMZ landmine blasts 'violation of armistice': Seoul
Viruses that could save millions of lives
It may seem strange after a pandemic that has killed millions and turned the world upside down, but viruses could save just as many lives.
In a petri dish in a laboratory in the Georgian capital Tbilisi, a battle is going on between antibiotic resistant bacteria and "friendly" viruses.
This small nation in the Caucasus has pioneered research on a groundbreaking way to tackle the looming nightmare of bacteria becoming resistant to the antibiotics on which the world depends.
Long overlooked in the West, bacteriophages or bacteria-eating viruses are now being used on some of the most difficult medical cases, including a Belgian woman who developed a life-threatening infection after being injured in the 2016 Brussels airport bombing.
After two years of unsuccessful antibiotic treatment, bacteriophages sent from Tbilisi cured her infection in three months.
"We use those phages that kill harmful bacteria" to cure patients when antibiotics fail, Mzia Kutateladze of the Eliava Institute of Bacteriophages told AFP.
Even a banal infection can "kill a patient because the pathogen has developed resistance to antibiotics," Kutateladze said.
In such cases, phagotherapy "is one of the best alternatives", she added.
Phages have been known about for a century, but were largely forgotten and dismissed after antibiotics revolutionised medicine in the 1930s.
- Stalin's henchman -
It didn't help that the man who did most to develop them, Georgian scientist Giorgi Eliava, was executed in 1937 on the orders of another Georgian, Lavrentiy Beria, Stalin's most notorious henchman and the head of his secret police.
Eliava had worked in the Pasteur Institute in Paris with French-Canadian microbiologist Felix d'Herelle, one of the two men credited with discovering phages, and persuaded Stalin to invite him to Tbilisi in 1934.
But their collaboration was cut short when Beria had Eliava killed, although his motive still remains a mystery.
With the World Health Organization now declaring antimicrobial resistance a global health crisis, phages are making a comeback, especially as they can target bacteria while leaving human cells intact.
A recent study warned that superbugs could kill as many as 10 million people a year when antimicrobial resistance due to overuse of antibiotics reaches a tipping point. That could come within three decades.
- 'Training' viruses -
While phages-based medicines cannot completely replace antibiotics, researchers say they have major pluses in being cheap, not having side-effects nor damaging organs or gut flora.
"We produce six standard phages that are of wide spectrum and can heal multiple infectious diseases," said Eliava Institute physician Lia Nadareishvili.
In some 10 to 15 percent of patients, however, standard phages don't work and "we have to find ones capable of killing the particular bacterial strain," she added.
Tailored phages to target rare infections can be selected from the institute's massive collection -- the world's richest -- or be found in sewage or polluted water or soil, Kutateladze said.
The institute can even "train" phages so that "they can kill more and more different harmful bacteria."
"It is a cheap and easily accessible therapy," she added.
- Last-resort treatment -
A 34-year-old American mechanical engineer suffering from a chronic bacterial disease for six years told AFP he "already felt improvement" after two weeks at the Tbilisi institute.
"I've tried every possible treatment in the United States," said Andrew, who would only give his first name.
He is one of the hundreds of patients from around the globe who arrive in Georgia every year for last-resort treatment, said Nadareishvili.
With the traditional antimicrobial armoury depleting rapidly, more clinical studies are needed so that phagotherapy can be more widely approved, Kutateladze argued.
In 2019, the United States Food and Drug Administration (FDA) authorised a clinical study on the use of bacteriophages to cure secondary infections in Covid patients.
Beyond medicine, phages are already being used to stop food going off, and they "can be used in agriculture to protect crops and animals from harmful bacteria," Kutateladze said.
The institute has already conducted research on bacteria targeting cotton and rice.
Bacteriophages also have potential to counter biological weapons and combat bioterrorism, with Canadian researchers publishing a 2017 study on using them to counter an anthrax attack on crowded public places.
Ch.Campbell--AT